Fluticasone Furoate + Umeclidinium + Vilanterol

Category: Lungs (Pulmonary)

Fluticasone Furoate + Umeclidinium + Vilanterol Overview

Vilanterol (INN, USAN) is an ultra-long-acting β2 adrenoreceptor agonist (ultra-LABA), which was approved in May 2013 in combination with fluticasone furoate for sale as Breo Ellipta by GlaxoSmithKline for the treatment of chronic obstructive pulmonary disease (COPD).[1] Vilanterol is available in following combinations: with inhaled corticosteroid fluticasone furoate — fluticasone furoate/vilanterol (trade names Breo Ellipta (U.S.), Relvar Ellipta (EU, RU, JPN)) w...

Read more Fluticasone Furoate + Umeclidinium + Vilanterol Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Vilanterol

Recent Fluticasone Furoate + Umeclidinium + Vilanterol Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Drugs with one or more similar ingredients: (9 results)

• TRELEGY ELLIPTA Fluticasone Furoate + Umeclidinium + Vilanterol2 discussions
• ANORO ELLIPTA Umeclidinium + Vilanterol2 discussions
• ARNUITY ELLIPTA Fluticasone Furoate
• BREO ELLIPTA Fluticasone Furoate + Vilanterol Trifenatate2 discussions
• FLUTICASONE FUROATE + VILANTEROL TRIFENATATE
• INCRUSE ELLIPTA Umeclidinium Bromide1 discussion
• UMECLIDINIUM + VILANTEROL
• UMECLIDINIUM BROMIDE
• VERAMYST Fluticasone Furoate4 discussions

Related Fluticasone Furoate + Umeclidinium + Vilanterol Topics: